Sarepta Therapeutics (SRPT) submits Form 13F showing one entry and $0 value
Rhea-AI Filing Summary
Sarepta Therapeutics, Inc. filed a Form 13F as an institutional investment manager, indicating it is submitting a 13F holdings report. The summary page shows 1 information table entry with an aggregate reported value of $0, and no other included managers listed. The report is signed by Executive Vice President and Chief Financial Officer Ryan Wong.
Positive
- None.
Negative
- None.
Key Figures
Form 13F Information Table Entry Total: 1
Form 13F Information Table Value Total: 0
Number of Other Included Managers: 0
3 metrics
Form 13F Information Table Entry Total
1
Total number of entries in the Form 13F information table
Form 13F Information Table Value Total
0
Aggregate value of reportable holdings, rounded to nearest dollar
Number of Other Included Managers
0
Count of additional managers included in this Form 13F report
Key Terms
Form 13F, Institutional Investment Manager, 13F HOLDINGS REPORT
3 terms
Form 13F regulatory
"FORM 13F FORM 13F COVER PAGE"
A Form 13F is a quarterly filing that large investment managers must submit to disclose their holdings in publicly traded stocks and certain other securities. It acts like a peek into the portfolios of big investors, helping other market participants see what large players are buying or selling and offering clues about investment trends, crowded trades, and potential market impact.
Institutional Investment Manager regulatory
"The institutional investment manager filing this report"
13F HOLDINGS REPORT regulatory
"Report Type (Check only one.) X | 13F HOLDINGS REPORT."
FAQ
What did Sarepta Therapeutics (SRPT) file with the SEC in this document?
Sarepta Therapeutics filed a Form 13F holdings report as an institutional investment manager, disclosing a summary with one information table entry and an aggregate reported value of $0 for its reportable positions.
How many holdings entries did Sarepta Therapeutics (SRPT) report on its Form 13F?
The Form 13F summary shows 1 information table entry in total. This means Sarepta reported one line item in its 13F information table, although the aggregate value for these reportable holdings is listed as $0.
What total value of securities did Sarepta Therapeutics (SRPT) report on Form 13F?
The Form 13F summary lists a Form 13F Information Table Value Total of $0. This figure is rounded to the nearest dollar and represents the aggregate reported value of the manager’s reportable 13F holdings for the period.
Are there any other included managers in Sarepta Therapeutics’ (SRPT) Form 13F report?
No. The report summary shows the Number of Other Included Managers is 0, and the separate section listing other included managers states “NONE”, indicating no additional managers are part of this filing.
Who signed the Sarepta Therapeutics (SRPT) Form 13F and in what capacity?
The Form 13F is signed by Ryan Wong, who is identified as Executive Vice President, Chief Financial Officer. The signature block indicates he is authorized to submit the report and certify that the information provided is true, correct, and complete.
AI-generated analysis. How Rhea-AI works. Not financial advice.
